DRIERITE

Hazard statements (CLP)

H302, H317, H334, H341, H350, H360, H411

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause cancer. Suspected of causing genetic defects. May damage fertility or the unborn child. Harmful if swallowed. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. Toxic to aquatic life with long lasting effects

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Danger

Contains

CALCIUM SULPHATE; COBALT DICHLORIDE

Hazard statements

H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 - Suspected of causing genetic defects. H350 - May cause cancer. H360 - May damage fertility or the unborn child. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust. P280 - Wear eye protection, protective clothing, protective gloves. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P321 - Specific treatment (see supplemental first aid instruction on this label).

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component COBALT DICHLORIDE (7646-79-9) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component COBALT DICHLORIDE (7646-79-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Germ cell mutagenicity, Category 2 H341 Carcinogenicity, Category 1B H350 Reproductive toxicity, Category 1B H360 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause cancer. Suspected of causing genetic defects. May damage fertility or the unborn child. Harmful if swallowed. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. Toxic to aquatic life with long lasting effects.